GABRG2 rs5968255: Understanding Epilepsy Risk Associations
The rs5968255 variant is a genetic marker located within the GABRG2 gene, which provides instructions for creating a critical component of the brain's inhibitory signaling system. Research has investigated this variant for its potential statistical association with altered receptor expression and an increased risk for certain types of epilepsy.
What each genotype means
Typical GABRG2 expression profile
This genotype represents the most common genetic sequence observed in the general population for this specific location in the GABRG2 gene. Research indicates that this variant is part of the normal genetic diversity of the GABRG2 gene, which is essential for proper GABA-A receptor function in the brain. There is no evidence suggesting this specific genotype independently increases the risk of epilepsy or other neurological conditions.
This is the most frequent genotype observed across most global populations.
Common genetic variation
Carrying one copy of the G allele is a common occurrence and is generally considered part of normal human genetic variation. While the GABRG2 gene is known to be associated with epilepsy and febrile seizures when specific rare, pathogenic mutations are present, this common variant is not typically classified as a disease-causing mutation. It does not require specific medical action or clinical intervention.
This heterozygous genotype is found at varying frequencies across global populations, appearing in a significant portion of the general public.
Common genetic variation
This genotype represents the alternative common sequence at this position in the GABRG2 gene. Like the other common genotypes for this variant, it is not associated with the rare, pathogenic mutations that cause GABRG2-related epilepsy syndromes. It is considered a normal variation in the human genome.
This genotype is common and observed frequently in diverse ancestral groups.
What is rs5968255 and Where is it Located?
The rs5968255 variant is a single nucleotide polymorphism (SNP) situated within the GABRG2 gene. In genetics, a SNP represents a variation at a single position in the DNA sequence among individuals. The GABRG2 gene is located on human chromosome 5 and is responsible for encoding the gamma-2 subunit of the GABA-A receptor. Because this variant sits within a gene that is vital for neurological function, researchers often study such markers to determine if they influence how the body builds or regulates these receptors. While many SNPs are neutral, those located in functional genes are prioritized in studies to see if they correlate with specific health traits or conditions, such as neurological disorders.
The Role of the GABRG2 Gene
The GABRG2 gene plays a fundamental role in the central nervous system by encoding the gamma-2 subunit of the GABA-A receptor. GABA-A receptors are ligand-gated chloride channels that mediate fast inhibitory neurotransmission. When GABA, a primary inhibitory neurotransmitter, binds to these receptors, it allows chloride ions to flow into neurons, which reduces neuronal excitability and helps maintain a balance between excitation and inhibition in the brain. The gamma-2 subunit is particularly important for the proper trafficking and clustering of these receptors at synapses. When the function of these receptors is impaired due to genetic variations, the brain may become overly excitable, which is a hallmark of various epilepsy syndromes and seizure disorders.
Research Associations and Evidence Strength
Scientific literature has explored the link between GABRG2 variants and epilepsy, including conditions like childhood absence epilepsy and febrile seizures. While rare, highly penetrant mutations in GABRG2 are known to cause severe epileptic encephalopathies, the evidence for common variants like rs5968255 is generally considered moderate. Studies often look for statistical correlations between specific alleles and the prevalence of seizure disorders in patient populations compared to healthy controls. It is important to note that while some studies have identified associations between GABRG2 polymorphisms and epilepsy risk, these findings are often complex and may not be consistent across all ethnic groups or populations. The evidence suggests that GABRG2 variants may contribute to a genetic predisposition, but they are rarely the sole cause of epilepsy in a given individual.
Population Frequency
The rs5968255 variant is classified as a common variant, meaning it appears frequently across diverse human populations. Because it is common, it is present in a large portion of the general population who do not have epilepsy, which underscores that carrying this variant does not equate to a diagnosis. Genetic frequency can vary significantly based on ancestral background, and researchers use databases like gnomAD to track these distributions. Understanding that a variant is common helps clinicians and researchers contextualize its role; it is more likely to act as a subtle modifier of risk rather than a direct, high-impact cause of disease.
What You Can and Cannot Do With This Information
Information regarding genetic variants like rs5968255 is intended for educational purposes and should not be used for self-diagnosis or medical decision-making. If you are concerned about epilepsy or seizure history, it is essential to consult with a neurologist or a genetic counselor who can interpret your specific health history in the context of your genetics. You cannot use a single SNP result to predict your health outcomes, as complex conditions like epilepsy are influenced by a combination of many genes, environmental factors, and lifestyle. Always discuss any genetic testing results with a qualified healthcare professional before making changes to your medical care or treatment plans.
How common is this variant?
The rs5968255 variant is a common polymorphism found across global populations, with its specific allele frequencies varying by ancestry.
Frequently asked questions
Does having the rs5968255 variant mean I will develop epilepsy?
No. Having this variant does not mean you will develop epilepsy. Epilepsy is a complex condition influenced by many genetic and environmental factors, and this variant is common in the general population.
Is GABRG2 associated with other conditions?
Yes, rare and severe mutations in the GABRG2 gene have been linked to various forms of epilepsy, including Dravet syndrome and febrile seizures. However, common variants like rs5968255 have a much less clear impact on health.
Should I get tested for GABRG2 variants?
Genetic testing for epilepsy is typically reserved for individuals with a clinical diagnosis or a strong family history. You should discuss the necessity of such testing with a neurologist or genetic counselor.
How do I interpret my genetic report for this SNP?
Genetic reports for common SNPs should be interpreted with caution. Because the association with disease is often weak or statistical in nature, these results are best discussed with a healthcare professional who can provide context.
Sources & further reading
Educational information only, last refreshed 10/17/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs5968255?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in GABRG2
This variant in the GABRG2 gene is associated with variations in response to certain anticonvulsant medications and epilepsy susceptibility.
Variant in GABRG2, a gene where mutations can alter GABA-A receptor function and influence seizure thresholds.
Mutations in GABRG2 are linked to a spectrum of epilepsy ranging from simple febrile seizures to severe developmental and epileptic encephalopathies.
This variant is located in the GABRG2 gene, which encodes the gamma-2 subunit of the GABA-A receptor; variants in this gene are associated with a spectrum of epilepsy syndromes.
A common variant in GABRG2, a gene encoding a GABA-A receptor subunit linked to various epilepsy phenotypes including febrile seizures and GEFS+.
Linked to GABA-A receptor subunit dysfunction, a known mechanism for inherited epilepsy syndromes.